Genentech Ophthalmology Co-pay Program - Vabysmo
Genentech, Inc. (Roche) · Vabysmo
Patient pays: as little as $0 per treatment
commercial insurance
How to apply: online or phone
Every Vabysmo assistance program you may qualify for - manufacturer and foundation programs, not a discount card. About a minute, no login.
Every Vabysmo program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Tell us five things. We’ll do the rest.
Vabysmo (faricimab-svoa) is an anti-vegf and anti-ang2 bispecific antibody (intravitreal) made by Roche / Genentech. It is commonly prescribed for: Neovascular (wet) age-related macular degeneration, Diabetic macular edema, Macular edema following retinal vein occlusion.
Income limits
1 of the 2 active Vabysmo assistance programs we track caps household income. The lowest cutoff is $150,000 a year for a single person.
The Genentech Patient Foundation - Vabysmo uses dollar income limits instead: $150,000 for households of up to 4 people, plus $25,000 for each additional member.
Each program makes the final eligibility decision - confirm on the official application linked above.
Vabysmo offers more than one kind of program, and they have opposite rules:
We show both programs, and the real income limits, below. Or read the full copay card vs patient assistance guide
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Genentech, Inc. (Roche) · Vabysmo
Patient pays: as little as $0 per treatment
commercial insurance
How to apply: online or phone
Genentech, Inc. (Roche) · Vabysmo
uninsured · underinsured
How to apply: online or phone
Yes. Genentech, Inc. (Roche) runs the Genentech Patient Foundation - Vabysmo, which provides Vabysmo free of charge to eligible patients. The full rules and the official application link are in the program list above.
Medicare coverage for Vabysmo depends on your own plan: depending on how it is given, a drug can fall under Part B (administered in a clinic) or Part D (filled at a pharmacy), and each plan decides what it covers. Your plan's documents or Medicare's plan finder are the only reliable check. Separate from coverage, none of the Vabysmo assistance programs we track currently accept Medicare patients.
Yes - the Genentech Ophthalmology Co-pay Program - Vabysmo from Genentech, Inc. (Roche). Eligible patients pay as little as $0 per treatment. It works for patients with commercial (private) insurance. Patients on Medicare or Medicaid cannot use the card itself. If you searched for a Vabysmo coupon, this manufacturer card is the official version of it.
The official application form for the Genentech Patient Foundation - Vabysmo is on vabysmo.com - the application links on this page go straight to the program's own form. Some programs call it an enrollment form; it is the same document. Applying is always free; never pay a third-party service to file a patient assistance form for you.
None of the Vabysmo programs we track currently accept Medicare or Medicaid. If that changes, we will update this page.
Manufacturers like Roche / Genentech use "patient support program" as an umbrella term for nurse lines, insurance navigation, and financial help. The financial help is what we track here - for Vabysmo that is the Genentech Patient Foundation - Vabysmo. The support phone line is listed on the official program site linked above.